Searched for
ANIL SATWANI
Symbiotec Pharmalab plans IPO to boost specialty pharma marketSymbiotec Pharmalab, a leading API manufacturer, is planning an IPO. The company targets a valuation of about $1 billion. The IPO aims to r...
Indian drug firms cheer dexamethasone efficacy on severe COVID-19 patientsM P Gupta, general manager of Mahima Lifesciences, a Chandigarh-based steroid API maker, said the company was expecting a jump in raw mater...
MOPE and InvAscent buy 70% in Symbiotec for $100 mPE fund Actis sells the stake in API maker, valuing company at $140 m.